JP2006514981A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514981A5 JP2006514981A5 JP2004571002A JP2004571002A JP2006514981A5 JP 2006514981 A5 JP2006514981 A5 JP 2006514981A5 JP 2004571002 A JP2004571002 A JP 2004571002A JP 2004571002 A JP2004571002 A JP 2004571002A JP 2006514981 A5 JP2006514981 A5 JP 2006514981A5
- Authority
- JP
- Japan
- Prior art keywords
- independently
- alkyl
- moiety
- following structure
- aryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 0 *C(C1O)[C@](*)*C(CO)[C@]1O*I Chemical compound *C(C1O)[C@](*)*C(CO)[C@]1O*I 0.000 description 8
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43082202P | 2002-12-03 | 2002-12-03 | |
| US50016103P | 2003-09-04 | 2003-09-04 | |
| US50070803P | 2003-09-05 | 2003-09-05 | |
| PCT/US2003/038471 WO2004050711A2 (en) | 2002-12-03 | 2003-12-03 | Gp120 specific antigens, conjugates thereof, methods for their preparation and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514981A JP2006514981A (ja) | 2006-05-18 |
| JP2006514981A5 true JP2006514981A5 (enExample) | 2009-05-14 |
Family
ID=32475412
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004571002A Pending JP2006514981A (ja) | 2002-12-03 | 2003-12-03 | Ｇｐ１２０特異抗原、その結合体；その調製と使用のための方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US7531181B2 (enExample) |
| EP (1) | EP1569955A2 (enExample) |
| JP (1) | JP2006514981A (enExample) |
| AU (1) | AU2003302235A1 (enExample) |
| CA (1) | CA2508539A1 (enExample) |
| WO (1) | WO2004050711A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7824687B2 (en) | 1999-08-20 | 2010-11-02 | Sloan-Kettering Institute For Cancer Research | Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof |
| US7879335B1 (en) | 1999-08-20 | 2011-02-01 | Sloan-Kettering Institute For Cancer Research | Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| US7854934B2 (en) | 1999-08-20 | 2010-12-21 | Sloan-Kettering Institute For Cancer Research | Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| JP2006514981A (ja) | 2002-12-03 | 2006-05-18 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Ｇｐ１２０特異抗原、その結合体；その調製と使用のための方法 |
| WO2005078443A1 (en) * | 2004-02-13 | 2005-08-25 | Inverness Medical Switzerland Gmbh | Determination of infection by the immune response to a carbohydrate moiety |
| JP2008533175A (ja) * | 2005-03-16 | 2008-08-21 | ユニバーシティ・オブ・オックスフォード | Ｈｉｖ−１のためのマンノース免疫原 |
| JP2009509970A (ja) * | 2005-09-22 | 2009-03-12 | プロサイ インコーポレイテッド | 酵母突然変異体において産生されるグリコシル化ポリペプチドおよびその使用方法 |
| CA2649303C (en) | 2006-04-11 | 2016-09-27 | Sloan-Kettering Institute For Cancer Research | Homogeneous erythropoietin and other peptides and proteins, methods and intermediates for their preparation |
| TWI432448B (zh) * | 2006-09-14 | 2014-04-01 | Univ Duke | 疫苗 |
| JP2010516784A (ja) * | 2007-01-29 | 2010-05-20 | ユニバーシティ・オブ・オックスフォード | 糖免疫原 |
| EP2138513B1 (en) | 2008-06-27 | 2011-02-09 | Theranor SPRL | Pharmaceutical compositions of antibodies for diseases caused by viruses |
| US9598466B2 (en) | 2008-07-11 | 2017-03-21 | Sloan-Kettering Institute For Cancer Research | Glycopeptide constructs and uses thereof |
| US20110136729A1 (en) * | 2009-05-26 | 2011-06-09 | Shien Lu | Occidiofungin, a unique antifungal glycopeptide produced by a strain of burkholderia contaminans |
| WO2011026111A1 (en) | 2009-08-31 | 2011-03-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Oral delivery of a vaccine to the large intestine to induce mucosal immunity |
| AU2011237393B2 (en) | 2010-04-08 | 2015-01-22 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | B-cell antigen presenting cell assay |
| AU2011265184B2 (en) | 2010-06-11 | 2016-08-04 | Sloan-Kettering Institute For Cancer Research | Multivalent glycopeptide constructs and uses thereof |
| EP2925774B8 (en) | 2012-11-29 | 2018-03-07 | The Texas A&M University System | Engineering the production of a conformational variant of occidiofungin that has enhanced inhibitory activity against fungal species |
| EP3191114B1 (en) | 2014-09-12 | 2021-03-03 | Mississippi State University | Occidiofungin formulations and uses thereof |
| JP7005504B2 (ja) | 2016-02-22 | 2022-01-21 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | 生体分子の固定化方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2047073A1 (en) * | 1990-07-19 | 1992-01-20 | William J. Leanza | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties |
| CA2059692C (en) * | 1991-01-28 | 2004-11-16 | Peter J. Kniskern | Pneumoccoccal polysaccharide conjugate vaccine |
| BR9809149A (pt) * | 1997-05-20 | 2000-08-01 | Galenica Pharmaceuticals Inc | Análogos de triterpeno saponina dotados de adjuvante e atividade imonoestimulatória |
| US6080725A (en) * | 1997-05-20 | 2000-06-27 | Galenica Pharmaceuticals, Inc. | Immunostimulating and vaccine compositions employing saponin analog adjuvants and uses thereof |
| WO2004033663A2 (en) * | 2002-10-11 | 2004-04-22 | University Of Maryland Biotechnology Institute Off. Of Research Admin./ Tech. Dev. | Carbohydrate-based synthetic vaccines for hiv |
| WO2004060915A2 (en) | 2002-12-03 | 2004-07-22 | Sloan-Kettering Institute For Cancer Research | Prostate specific antigens, conjugates thereof, methods for their preparation and uses thereof. |
| JP2006514981A (ja) | 2002-12-03 | 2006-05-18 | スローン − ケッタリング インスティチュート フォー キャンサー リサーチ | Ｇｐ１２０特異抗原、その結合体；その調製と使用のための方法 |
-
2003
- 2003-12-03 JP JP2004571002A patent/JP2006514981A/ja active Pending
- 2003-12-03 AU AU2003302235A patent/AU2003302235A1/en not_active Abandoned
- 2003-12-03 EP EP03810054A patent/EP1569955A2/en not_active Withdrawn
- 2003-12-03 CA CA002508539A patent/CA2508539A1/en not_active Abandoned
- 2003-12-03 WO PCT/US2003/038471 patent/WO2004050711A2/en not_active Ceased
-
2005
- 2005-06-03 US US11/145,084 patent/US7531181B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006514981A5 (enExample) | ||
| Roy | Recent developments in the rational design of multivalent glycoconjugates | |
| Roy et al. | Glycodendrimers: novel glycotope isosteres unmasking sugar coding. Case study with T-antigen markers from breast cancer MUC1 glycoprotein | |
| Galan et al. | Multivalent glyco (cyclo) peptides | |
| Niederhafner et al. | Glycopeptide dendrimers, Part III—a review: use of glycopeptide dendrimers in immunotherapy and diagnosis of cancer and viral diseases | |
| Pieters et al. | Application of the 1, 3‐Dipolar Cycloaddition Reaction in Chemical Biology: Approaches Toward Multivalent Carbohydrates and Peptides and Peptide‐Based Polymers | |
| JP3181276B2 (ja) | 樹枝状分岐構造を持つ両親媒性化合物 | |
| Shiao et al. | Glycodendrimers as functional antigens and antitumor vaccines | |
| DK1850832T3 (en) | adjuvanting | |
| FI66878B (fi) | Foerfarande foer framstaellning av nya antigenderivat | |
| AU2003224878B2 (en) | Synthetic glyco-lipo-peptides as vaccines | |
| US7531181B2 (en) | Gp120 specific antigens and uses thereof | |
| HU195620B (en) | Process for producing conjugates with immunogenic effect and built up from haptenes and muramylpeptides and pharmaceutics comprising these conjugates | |
| JPH11508564A (ja) | 合成ｎ−結合グリココンジュゲートを製造するための方法 | |
| JP2010540488A (ja) | 糖タンパク質及びグリコシル化細胞及びそれらの調製方法 | |
| Ribić et al. | Advances in desmuramyl peptide research | |
| EP2407178A2 (en) | Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease | |
| Roy et al. | Organic chemistry and immunochemical strategies in the design of potent carbohydrate-based vaccines | |
| Hevey et al. | Conjugation Strategies Used for the Preparation of Carbohydrate‐Conjugate Vaccines | |
| Kihlberg et al. | Use of carbohydrates and peptides in studies of adhesion of pathogenic bacteria and in efforts to generate carbohydrate-specific T cells | |
| JP2007527864A (ja) | 自然に起こる化学的連結による、多官能化ペプチドおよび／またはタンパク質の調製方法 | |
| Fernandez-Santana et al. | Conjugation of 5-azido-3-oxapentyl glycosides with thiolated proteins through the use of thiophilic derivatives | |
| Vepřek | Desing and synthesis of Tn-bearing glycodendrimers and their interaction with components of innate and adaptive immunity | |
| CZ278551B6 (en) | Polymeric medicament, process for preparing thereof and pharmaceutical compositions based thereon | |
| AU2006207368A1 (en) | Method of producing conjugate vaccines |